We are live on ! Find out more
TFFP

TFF Pharmaceuticals, Inc. Common Stock
TFFP

Delisted

TFFP was delisted on the 12th of December, 2024.

Back to rankings

63 hedge funds and large institutions have $96.1M invested in TFF Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

56% more call options, than puts

Call options by funds: $3.3M | Put options by funds: $2.11M

34% more funds holding

Funds holding: 47 → 63 (+16)

4% more capital invested

Capital invested by funds: $92.8M → $96.1M (+$3.26M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
63
Holders Change
+16
Holders Change %
+34.04%
% of All Funds
1.11%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
19
Reduced
11
Closed
8
Calls
$3.3M
Puts
$2.11M
Net Calls
+$1.19M
Net Calls Change
+$2.31M

Top Buyers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
+$8.35M
2
ACM
Altium Capital Management
New York
+$4.39M
3
CA
Corriente Advisors
Texas
+$3.51M
4
GPCM
Granite Point Capital Management
Massachusetts
+$3.42M
5
IAM
Iridian Asset Management
Connecticut
+$3.32M

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$22.5M
2
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
-$3.23M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$2.36M
4
6CM
683 Capital Management
New York
-$2.03M
5
SC
Sepio Capital
Utah
-$1.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
DC
26
Diametric Capital
Massachusetts
$446K +$535K +1,315 New
First Trust Advisors
27
First Trust Advisors
Illinois
$420K +$40.3K +99 +9%
IA
28
IndexIQ Advisors
New York
$414K +$496K +1,220 New
MFIM
29
Mesirow Financial Investment Management
Illinois
$369K -$12.2K -30 -3%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$349K – – –
Belvedere Trading
31
Belvedere Trading
Illinois
$317K +$381K +936 New
UOTTAIMCU
32
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$299K -$3.23M -7,944 -90%
PCM
33
Prelude Capital Management
New York
$293K +$351K +863 New
Northern Trust
34
Northern Trust
Illinois
$292K +$1.63K +4 +0.5%
SMH
35
Sanders Morris Harris
Texas
$278K – – –
CSS
36
Cubist Systematic Strategies
Connecticut
$257K +$309K +759 New
Citigroup
37
Citigroup
New York
$240K -$63K -155 -18%
Morgan Stanley
38
Morgan Stanley
New York
$233K +$268K +658 +2,193%
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
$224K – – –
Goldman Sachs
40
Goldman Sachs
New York
$189K +$227K +558 New
WHG
41
Westwood Holdings Group
Texas
$185K – – –
TI
42
Trexquant Investment
Connecticut
$184K +$220K +542 New
Two Sigma Advisers
43
Two Sigma Advisers
New York
$182K +$218K +536 New
Stifel Financial
44
Stifel Financial
Missouri
$176K +$211K +520 New
Creative Planning
45
Creative Planning
Kansas
$167K +$200K +493 New
FA
46
Fermata Advisors
California
$167K +$207K +508 New
PP
47
PDT Partners
New York
$166K +$198K +488 New
MWA
48
Meridian Wealth Advisors
Texas
$156K – – –
LP
49
LMR Partners
United Kingdom
$140K +$168K +413 New
BWP
50
Baldwin Wealth Partners
Massachusetts
$136K – – –
1
2
3

TFFP Hedge Fund Activity: Q1 2021 in Review

63 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q1 2021, worth a combined $96.1M — up 3.5% from $92.8M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new TFFP positions and 8 closed out — a net gain of 16 holders — while 19 added to existing stakes and 11 trimmed.

The largest buyer was DRW Securities, opening a new position worth an estimated $8.35M. The largest seller was Nantahala Capital Management, cutting an estimated $22.5M.

  • 63 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q1 2021, up from 47 in Q4 2020.
  • Funds reported $96.1M of TFF Pharmaceuticals, Inc. Common Stock stock for Q1 2021, up 3.5% quarter-over-quarter.
  • 24 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q1 2021 and 8 closed out, a net change of +16 holders.
  • The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q1 2021 was DRW Securities, an estimated $8.35M added.
  • The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q1 2021 was Nantahala Capital Management, an estimated $22.5M sold.

Based on aggregated 13F filings for Q1 2021.